Citizens & Northern Corp Merck & Co., Inc. Transaction History

Citizens & Northern Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$72.28 - $90.54 $253,702 - $317,795	-3,510 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $45,929 - $54,100	-667 Reduced 15.97%	3,510 $271,000
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $42,128 - $46,754	587 Added 16.35%	4,177 $342,000
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $15,840 - $21,955	-250 Reduced 6.51%	3,590 $276,000
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $19,395 - $21,885	250 Added 6.96%	3,840 $349,000
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $10,476 - $12,238	-150 Reduced 4.01%	3,590 $301,000
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $6,958 - $7,936	-100 Reduced 2.6%	3,740 $311,000
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $8,653 - $10,176	150 Added 4.07%	3,840 $272,000
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $16,154 - $18,775	-317 Reduced 7.91%	3,690 $201,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $23,468 - $25,252	400 Added 11.09%	4,007 $257,000
Q2 2017 Aug 11, 2017	BUY	N/A	3,607	3,607 $231,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Citizens & Northern Corp, based on Form 13F filings with the SEC.

Stay updated on Citizens & Northern Corp with notifications on news.